The following NICE technology appraisals have been allocated to ScHARR-TAG:
- Methadone and buprenorphine for drug misuse (Review 114) (MTA).
- Tapentadol for severe chronic pain requiring centrally acting analgesia (STA).
- Rivaroxaban for the treatment and secondary prevention of venous thromboembolism (STA).
- Gastric Cancer - S1 (STA)
Contact Eva Kaltenthaler or Matt Stevenson for further details.